SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLN.L Regulatory News (SLN)

  • There is currently no data for SLN

Potential Offer

6 Sep 2010 15:14

RNS Number : 2239S
Silence Therapeutics PLC
06 September 2010
 



 

 

FOR IMMEDIATE RELEASE

 

Potential Offer

 

London, 6 September, 2010 - Silence Therapeutics plc (AIM: SLN) notes the recent share price movement and announces that it has received an approach which may or may not lead to an offer for the Company. A further announcement will be made in due course.

 

For further information, please contact:

 

Silence Therapeutics

Phil Haworth, CEO +1 (650) 855-1514

p.haworth@silence-therapeutics.com

NOMAD

Nomura Code Securities

Richard Potts / Jonathan Senior

+44 20 7776 1200

 

European media and investor enquiries:

M:Communications +44 20 7920 2342

Mary-Jane Elliott / Emma Thompson

 

US media and investor enquiries:

Vida Communication +44 (415) 675-7400

Tim Brons (media)

tbrons@vidacommunication.com 

or

Stephanie Diaz (investors)

sdiaz@vidacommunication.com

 

The City Code on Takeovers and Mergers (the "City Code")

 

1) Rule 2.10 of the City Code

 

In accordance with Rule 2.10 of the City Code, the Company confirms that it has 279,891,452 ordinary shares of 1p each in issue under the ISIN code GB0008433350.

 

2) Disclosure requirements of the Takeover Code (the "Code")

 

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any paper offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any paper offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any paper offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a paper offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any paper offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any paper offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a paper offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4). Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. If you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure, you should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SPMZQLFBBKFBBBK
Date   Source Headline
22nd Oct 200712:49 pmPRNHolding(s) in Company
9th Oct 200710:58 amPRNIssue of Equity
2nd Oct 20071:30 pmPRNDirector/PDMR Shareholding
28th Sep 20077:00 amPRNHalf-yearly Report
26th Sep 200711:28 amPRNHolding(s) in Company
10th Sep 20077:00 amPRNResearch Update
6th Sep 20077:05 amPRNNotice of Results
4th Sep 20077:30 amPRNHolding(s) in Company
24th Aug 20074:10 pmPRNHolding(s) in Company
23rd Aug 200712:45 pmPRNHolding(s) in Company
20th Aug 20071:08 pmPRNHolding(s) in Company
16th Aug 200710:12 amPRNHolding(s) in Company
15th Aug 20073:25 pmPRNAIM Rule 26
15th Aug 20072:52 pmPRNHolding(s) in Company
9th Aug 20072:18 pmPRNHolding(s) in Company
9th Aug 20077:01 amRNSHolding(s) in Company
2nd Aug 20073:53 pmPRNHolding(s) in Company
2nd Aug 200710:55 amPRNResult of AGM
31st Jul 200710:27 amPRNTotal Voting Rights
31st Jul 20077:00 amPRNRe Agreement
27th Jul 20077:00 amPRNDirectorate Change
27th Jul 20077:00 amPRNDirectorate Change
20th Jul 200711:35 amPRNHolding(s) in Company
13th Jul 20074:09 pmPRNHolding(s) in Company
11th Jul 20073:37 pmPRNHolding(s) in Company
10th Jul 200712:56 pmPRNHolding(s) in Company
9th Jul 20072:27 pmPRNNotice of AGM
9th Jul 200711:01 amPRNHolding(s) in Company
6th Jul 20074:51 pmPRNIssue of Equity
6th Jul 20071:00 pmPRNRe Agreement
2nd Jul 20074:06 pmPRNIssue of Equity
29th Jun 20077:00 amPRNAnnual Report and Accounts
26th Jun 200711:33 amPRNTotal Voting Rights
21st Jun 20073:28 pmPRNHolding(s) in Company
20th Jun 20071:55 pmPRNCorrection : Holding(s) in Company
15th Jun 20077:00 amRNSConference Attendance
14th Jun 20077:00 amPRNIssue of Equity
13th Jun 20073:20 pmPRNHolding(s) in Company
6th Jun 200711:15 amPRNHolding(s) in Company
30th May 20077:05 amPRNHolding(s) in Company
29th May 20074:20 pmPRNHolding(s) in Company
29th May 200710:44 amPRNHolding(s) in Company
21st May 20073:37 pmPRNIssue of Equity
11th May 20074:26 pmPRNHolding(s) in Company
9th May 200711:45 amPRNIssue of Equity
4th May 20077:01 amRNSSR Pharma Name Change
30th Apr 20071:50 pmPRNTotal Voting Rights
26th Apr 200710:30 amPRNEGM Statement & Research Update
23rd Apr 20077:05 amPRNIssue of Equity
3rd Apr 20079:45 amPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.